Q2 FY2026 Earnings
Financial report interval: 2026.03.30 - 2026.06.30
Overview: Xenetic Biosciences(XBIO) the Revenue is 660.6 K (+11.99%);the EBIT is -971.69 K (-34.13%);the EPS is -0.405 (+9.27%).
Actual
YoY
Estimate
YoY
Vs estimate
YoY
Revenue
0.00B11.99%
----
----
EBIT
-0.00B34.13%
----
----
EPS
-0.40529.27%
----
----
Revenue
ActualEstimateUnit: USD
qf
EBIT
ActualEstimateUnit: USD
qf
Net income
ActualEstimateUnit: USD
qf
EPS
ActualEstimateUnit: USD
qf